Access detailed search options for content from the Clinical Journal of Oncology Nursing & Oncology Nursing Forum below.
Patients receiving standard chemotherapy regimens for solid tumors are at lower risk for development of febrile neutropenia and infection than patients who undergo bone marrow or stem cell transplantation.
Breakthrough pain is sudden, brief pain that occurs during a period when chronic pain is generally well controlled (typically, controlled with opiods).
Gastrointestinal side effects with immunotherapy can manifest as diarrhea, abdominal pain, or melena.
Intractable pain or refractory pain occurs when pain cannot be adequately controlled despite aggressive measures.
Chemotherapy-induced diarrhea is the abnormal increase in stool liquidity and frequency associated with the administration of chemotherapeutic agents.
Discover what you can learn with our compilation of resources to help expand your education around the safe handling of hazardous drugs. Explore articles, books, courses, podcasts, and more.
Intervention research regarding chemotherapy-induced nausea and vomiting (CINV) in adults consist of studies with sample subjects who are at least 18 years old.
Intervention research regarding CINV in pediatric patients consists of studies with subjects younger than 18 years old.
The use of oral anticancer medications continues to expand. Oncology nurses and their colleagues can benefit from a growing number of resources created to support patients taking these therapies.
A number of different types of cutaneous reactions that affect the skin, hair, and nails can occur with cancer treatment.